Skip to main content
. 2020 Dec 31;3(1):159–181. doi: 10.1089/nsm.2020.0009

Table 3.

Metabolite single-nucleotide polymorphisms explaining >15% of the variation in blood

Metabolite Super pathway Subpathway Variance explained rsID Consequence Closest gene Effect allele Other allele EAF p
N6-methyllysine Amino acid Lysine metabolism 0.50 rs2147896 Missense PYROXD2 A G 0.64 2.68×10−146
N6,N6-dimethyllysine Amino acid Lysine metabolism 0.48 rs2147896 Missense PYROXD2 A G 0.64 1.98×10−135
X - 12112 Unannotated Unannotated 0.44 rs7905265 Downstream gene PYROXD2 C G 0.64 6.00×10−119
N2-acetyl,N6,N6-dimethyllysine Amino acid Lysine metabolism 0.38 rs10182082 Intron NAT8 G C 0.22 6.07×10−38
0.15 rs7905265 Downstream gene PYROXD2 C G 0.64 1.86×10−97
N2-acetyl,N6-methyllysine Amino acid Lysine metabolism 0.34 rs7905265 Downstream gene PYROXD2 C G 0.64 5.04×10−88
0.25 rs10182082 Intron NAT8 G C 0.22 6.51×10−65
Ethylmalonate Amino acid Leucine, isoleucine and valine metabolism 0.30 rs1799958 Missense ACADS A G 0.25 5.87×10−79
0.01 rs6490297 Intergenic CABP1 C T 0.27 9.09×10−28
N-acetylarginine Amino acid Urea cycle; arginine and proline metabolism 0.27 rs10168931 Intron NAT8 A G 0.23 5.63×10−70
N-delta-acetylornithine Amino acid Urea cycle; arginine and proline metabolism 0.26 rs10168931 Intron NAT8 G A 0.77 2.02×10−64
N-acetyl-l-methylhistidine* Amino acid Histidine metabolism 0.25 rs10206899 Intron NAT8 C T 0.23 1.76×10−66
Butyrylcarnitine (C4) Lipid Fatty acid metabolism (also BCAA metabolism) 0.23 rs1799958 Missense ACADS A G 0.25 1.75×10−59
N-acetylglutamine Lipid Primary bile acid metabolism 0.22 rs4149056 Missense SLCO1B1 G T 0.16 4.51×10−39
N-methylpipecolate Xenobiotics Bacterial/Fungal 0.21 rs2147896 Missense PYROXD2 A G 0.64 6.75×10−54
Deoxycholic acid glucuronide Lipid Secondary bile acid metabolism 0.19 rs34594059 Intron TMPRSS11E C C 0.36 5.79×10−45
X - 19141 Unannotated Unannotated 0.17 rs34436963 3′ UTR TMPRSS11E G A 0.64 2.12×10−43
0.06 rs1165196 Missense SLC17A1 G A 0.45 3.08×10−17
1-Palmitoyl-GPI* (16:0) Lipid Lysophospholipid 0.16 rs102275 Intron TMEM258 T C 0.64 2.38×10−41
5alpha-androstan-3alpha,17alpha-diol monosulfate Lipid Androgenic steroid 0.16 rs1495741 Intergenic NAT2 G A 0.23 4.41×10 −41
0.01 rs1041983 Synonymous NAT2 C T 0.67 6.28×10−15
Glycochenodeoxycholate 3-sulfate Lipid Primary bile metabolism 0.16 rs4149056 Missense SLCO1B1 T T 0.16 4.51×10−39
0.01 rs11045913 Downstream gene SLCO1A2 G A 0.56 3.07×10−15
Decadienedioic acid (C10:2-DC)** Lipid Fatty acid, dicarboxylate 0.14 rs11621061 Intron HEATR4 C T 0.76 1.89×10−28
0.04 rs58231493 Upstream gene ACOT2 C T 0.56 8.80×10−32
3-Amino-2-piperidone Amino acid Urea cycle; arginine and proline metabolism 0.13 rs37369 Missense AGXT2 T C 0.08 6.06×10−33
0.04 rs16899974 Missense AGXT2 A C 0.22 9.31×10−17

Metabolite, metabolite annotation; super pathway, metabolite class annotation; subpathway, within class pathway annotation; variance explained, metabolite variance explained by genotype variation in mQTL SNP.

Total variance explained by mQTLs—metabolite variance explained by variation in all mQTL SNPs.

p-Value, p-value of regression test with SNP.

*

Indicates compounds that have not been officially confirmed based on a standard, but Metabolon is confident in its identity.

**

Indicates a compound for which a standard is not available, but Metabolon is confident in its identity or the information provided.

(#) or [#] indicates a compound that is a structural isomer of another compound in the Metabolon spectral library.

Ancestral allele, major allele; closest gene, closest gene to SNP as mapped in VEP; consequence, VEP annotation of variant; EAF, effect allele frequency in Discovery; effect allele, allele with positive association to metabolite; rsID, reference SNP ID number assigned by NCBI.

BCAA, branched chain amino acid; GPI, glycophosphatidylinositol; SNP, single-nucleotide polymorphism; VEP, Variant Effect Predictor.